InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Results from Drug Study Showing Improved Sleep Quality, Relief of Fibromyalgia Pain
Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering, is reporting positive study results for its sleep-quality targeted therapy. According to the report, the company’s product candidate Tonmya(R) reduced widespread pain in fibromyalgia reported by study participants. The company believes these results show potential for the drug to be…